Compare Mesoblast Limited (MESO) vs Paycom Software Inc (PAYC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Mesoblast Limited vs Paycom Software Inc — how do they compare? Mesoblast Limited trades at $16.38 (market cap $2.17B), while Paycom Software Inc trades at $144.05 (market cap $6.98B). The key difference: Paycom Software Inc is far larger — about 3.2× Mesoblast Limited's market cap, and Paycom Software Inc pays a 1% dividend while Mesoblast Limited pays none. Which is the better fit depends on your goals.
| MESO | PAYC | |
|---|---|---|
Market Cap | $2.17B | $6.98B |
Sector | Technology | Technology |
52-Week High | $20.96 | $238.80 |
52-Week Low | $12.88 | $113.59 |
Enterprise Value | $2.17B | $7.59B |
Dividend Yield | — | 1% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Mesoblast Limited
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →About Paycom Software Inc
Paycom is a fast-growing provider of payroll and human capital management, or HCM, software primarily targeting clients with 50-10,000 employees in the United States. Paycom was established in 1998 and services about 18,000 clients as of 2021, based on parent company grouping. Alongside its core payroll software, Paycom offers various HCM add-on modules, including time and attendance, talent management, and benefits administration.
Read more on PAYC →
